B cell depletion or absence does not impede anti-tumor activity of PD-1 inhibitors.
Damsky W, Jilaveanu L, Turner N, Perry C, Zito C, Tomayko M, Leventhal J, Herold K, Meffre E, Bosenberg M, Kluger HM.
Damsky W, et al.
J Immunother Cancer. 2019 Jun 14;7(1):153. doi: 10.1186/s40425-019-0613-1.
J Immunother Cancer. 2019.
PMID: 31200747
Free PMC article.